Figure 1From: Subcutaneously administered Menopur(R), a new highly purified human menopausal gonadotropin, causes significantly fewer injection site reactions than Repronex(R) in subjects undergoing in vitro fertilizationSubjects with hMG-Associated Injection Site Reactions. This figure shows the percentage of subjects with any hMG associated injection site reaction as well as those with reactions that included welts or inflammation and those whose reactions involved swelling.Back to article page